Bristol Myers Squibb Co. (BMY)
54.21
+0.10
(+0.18%)
USD |
NYSE |
Dec 30, 16:00
54.34
+0.13
(+0.24%)
Pre-Market: 05:33
Bristol Myers Squibb EPS Diluted (Quarterly): 1.079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.195B |
| Revenue (Quarterly) | 12.22B |
| Total Expenses (Quarterly) | 10.02B |
| Enterprise Value | 144.95B |
| Gross Profit Margin (Quarterly) | 66.00% |
| Profit Margin (Quarterly) | 17.96% |
| Earnings Yield | 5.46% |
| Operating Earnings Yield | 12.68% |
| Normalized Earnings Yield | 9.695 |